Related Experiment Video
Updated: Jun 23, 2026

Investigating Intestinal Inflammation in DSS-induced Model of IBD
Published on: February 1, 2012
The immune system in inflammatory bowel disease
1Division of Gastroenterology, University Hospitals of Cleveland, Case Western Reserve University School of Medicine, Ohio 44106 4952, USA.
Inflammatory bowel disease (IBD) involves immune system abnormalities in the gut, leading to inflammation and damage. Research focuses on mucosal events for understanding IBD pathogenesis and developing new treatments.
Area of Science:
- Immunology
- Gastroenterology
Background:
- Inflammatory bowel disease (IBD) is increasingly linked to immune system dysfunction.
- Evidence confirms the immune system's role in mediating gut inflammation and tissue damage in IBD patients.
Purpose of the Study:
- To elucidate the precise mechanisms of injury and triggers in IBD pathogenesis.
- To investigate mucosal immune responses for advancing IBD understanding and therapy development.
Main Methods:
- Analysis of systemic and mucosal immune abnormalities in IBD patients.
- Investigation of cellular and molecular events within the inflamed gut mucosa.
- Examination of humoral and cell-mediated immunity, cytokines, growth factors, and other mucosal components.
Main Results:
- Mucosal investigations provide significant insights into IBD pathogenesis, surpassing peripheral blood analyses.
- Abnormalities in various immune and non-immune mucosal components (e.g., cytokines, adhesion molecules, apoptosis) are implicated in IBD.
- The complexity of interactions among these components makes distinguishing primary from secondary phenomena challenging.
Conclusions:
- Understanding IBD pathogenesis requires a focus on mucosal events due to their direct relevance.
- Despite complexities, ongoing research is yielding valuable information for developing novel immunopathology-based treatments for IBD.
More Related Videos
08:37Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice
Published on: April 21, 2015
07:34Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
Published on: December 16, 2021
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease IV: Clinical Manifestations